Cargando…

Dilemma Concerning the Differential Diagnosis of Hematological Malignancy and Bone Metastasis Arising from Lung Cancer

Detalles Bibliográficos
Autor principal:	Kaira, Kyoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332967/ https://www.ncbi.nlm.nih.gov/pubmed/36351590 http://dx.doi.org/10.2169/internalmedicine.1050-22

Ejemplares similares

Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study
por: Imai, Hisao, et al.
Publicado: (2021)

Accuracy of diagnosis and individualization of treatment: the way of treating hematologic malignancies
por: Liu, Dai-Hong
Publicado: (2020)

Secondary osteosarcoma arising after treatment for childhood hematologic malignancies
por: Okada, Atsushi, et al.
Publicado: (2009)

Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders
por: Găman, Amelia Maria
Publicado: (2023)

Advanced Research on Immune Checkpoint Inhibitor Therapy
por: Imai, Hisao, et al.
Publicado: (2022)

Epiregulin as a therapeutic target in non-small-cell lung cancer
por: Sunaga, Noriaki, et al.
Publicado: (2015)

Drug Resistance in Hematological Malignancies
por: Auberger, Patrick, et al.
Publicado: (2020)

Nursing in patients with hematological malignancies
por: Geres, Hana, et al.
Publicado: (2020)

Immune Therapies for Hematologic Malignancies
por: Olnes, Matthew J.
Publicado: (2021)

Immune Microenvironment in Hematologic Malignancies
por: Arandi, Nargess, et al.
Publicado: (2023)

Massive splenomegaly requiring differential diagnosis of hematologic malignancies
por: Tago, Masaki, et al.
Publicado: (2022)

Clinical significance of post‐progression survival in lung cancer
por: Imai, Hisao, et al.
Publicado: (2017)

Neuroendocrine neoplasms in the breast oncology field: dilemmas of nature and morphology
por: Kawasaki, Tomonori, et al.
Publicado: (2023)

Molecular-Targeted Therapies for Hematologic Malignancies
por: Bunting, Kevin D., et al.
Publicado: (2012)

Diffuse bone marrow metastasis of cancer cells mimicking hematologic malignancy in a case of rhabdomyosarcoma
por: Wei, Chao‐Hung, et al.
Publicado: (2020)

The premier statistical report of hematologic malignancies in Korea
por: Kim, Hee-Je
Publicado: (2012)

The expected prisoner’s dilemma – With rationally arising cooperation
por: Arend, Richard J.
Publicado: (2020)

Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study
por: Kotake, Mie, et al.
Publicado: (2019)

Micronodular lung lesions in an HIV positive patient – dilemmas in differential diagnosis
por: Cambrea, Simona Claudia, et al.
Publicado: (2013)

Targeting Bone Metastasis in Cancers
por: Bonnelye, Edith, et al.
Publicado: (2021)

Drug Resistance in Hematologic Malignancies: Induction Mechanisms, Genetics, and Therapeutics
por: Zhan, Fenghuang, et al.
Publicado: (2015)

Preface of the Special Issue “COVID-19 Infection and Hematological Malignancies”
por: Chen, Mingyi, et al.
Publicado: (2022)

Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies
por: Marei, Hany E., et al.
Publicado: (2023)

Bone Marrow Senescence and the Microenvironment of Hematological Malignancies
por: Hellmich, Charlotte, et al.
Publicado: (2020)

Differential diagnosis of infectious diseases, drug-induced lung injury, and pulmonary infiltration due to underlying malignancy in patients with hematological malignancy using HRCT
por: Tanaka, Nobuyuki, et al.
Publicado: (2022)

Unusual presentation of lung carcinoma with pituitary metastasis: a challenging diagnosis and sodium management dilemmas
por: Wong, Poh Shean, et al.
Publicado: (2022)

Systemic treatment for primary malignant sarcomas arising in craniofacial bones
por: Bielack, Stefan S.
Publicado: (2022)

Chromosomal aberrations in hematological malignancies: A guide to the identification of novel oncogenes
por: Vundinti, Babu Rao, et al.
Publicado: (2011)

CXCR4 antagonists in hematologic malignancies: more than just mobilizers?
por: Jo, Deog-Yeon
Publicado: (2011)

Targeted Therapy in Hematological Malignancies: From Basic Research to Clinical Practice
por: Ma, Haiqing, et al.
Publicado: (2015)

For older adults with hematologic malignancies, a comprehensive geriatric assessment matters
por: Cordoba, Raul
Publicado: (2022)

Cancer survivorship in hematologic malignancies: Lifestyle changes after diagnosis
por: Malalur, Pannaga, et al.
Publicado: (2021)

Differential diagnosis of BPOP arising in relation to patella
por: Pal, Jitendra Nath, et al.
Publicado: (2015)

Severe gastritis due to pembrolizumab treatment in a lung cancer patient
por: Hayama, Noriko, et al.
Publicado: (2020)

The ACL Dilemma
por: Wojtys, Edward M.
Publicado: (2012)

Concussion Dilemma
por: Wojtys, Edward M.
Publicado: (2016)

The Epigenetics Dilemma
por: Grunau, Christoph, et al.
Publicado: (2019)

Clinical Effectiveness of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with a Poor Performance Status
por: Kaira, Kyoichi, et al.
Publicado: (2021)

Usefulness of Bone Metabolic Markers in the Diagnosis of Bone Metastasis from Lung Cancer
por: Chung, Jae Ho, et al.
Publicado: (2005)

Patients with hematological malignancies admitted to intensive care units: new challenges for the intensivist
por: Torres, Viviane Bogado Leite, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d959v8sbr2ppq0fqqbrbgd9feg